2-(4-Methyl-3-nitrophenylamino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)pyrimidine-5-carboxamide

ID: ALA3781859

Chembl Id: CHEMBL3781859

PubChem CID: 127032243

Max Phase: Preclinical

Molecular Formula: C27H21F3N6O4

Molecular Weight: 550.50

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1NC(=O)c1cnc(Nc2ccc(C)c([N+](=O)[O-])c2)nc1

Standard InChI:  InChI=1S/C27H21F3N6O4/c1-15-6-8-20(33-24(37)17-4-3-5-19(10-17)27(28,29)30)11-22(15)35-25(38)18-13-31-26(32-14-18)34-21-9-7-16(2)23(12-21)36(39)40/h3-14H,1-2H3,(H,33,37)(H,35,38)(H,31,32,34)

Standard InChI Key:  BWMPQCMAFPEXPM-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3781859

    ---

Associated Targets(Human)

K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Bcr/Abl fusion protein (1667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ABL1 Tclin Transcription factor ETV6/Tyrosine-protein kinase ABL1 (41 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 550.50Molecular Weight (Monoisotopic): 550.1576AlogP: 6.27#Rotatable Bonds: 7
Polar Surface Area: 139.15Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.52CX Basic pKa: 0.41CX LogP: 6.20CX LogD: 6.20
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.18Np Likeness Score: -1.84

References

1. Liang X, Liu X, Wang B, Zou F, Wang A, Qi S, Chen C, Zhao Z, Wang W, Qi Z, Lv F, Hu Z, Wang L, Zhang S, Liu Q, Liu J..  (2016)  Discovery of 2-((3-Amino-4-methylphenyl)amino)-N-(2-methyl-5-(3-(trifluoromethyl)benzamido)phenyl)-4-(methylamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia.,  59  (5): [PMID:26789553] [10.1021/acs.jmedchem.5b01618]

Source